O.M. Kuznetsova

О.М. Кузнецова

10 articles 2011–2012

2012

Soluble FAS Receptor and Breast Cancer Prognosis Вопросы биологической, медицинской и фармацевтической химии, No. 10, 2012 pp. 12-15
Redox-Dependent Change of Expression of Genes Encoding Isoforms of Peroxiredoxin in Cancer Cells Resistant to Doxorubicin Вопросы биологической, медицинской и фармацевтической химии, No. 8, 2012 pp. 27-33
Activators and inhibitors of angiogenesis in tumors Technologies of Living Systems, No. 3, 2012 pp. 49-57

Serum Vascular Endothelial Growth Factor Content in Localized Breast Cancer and its Prognostic Significance Technologies of Living Systems, No. 7, 2011 pp. 28-34
The Clinical Significance of Epidermal Growth Factor Receptor And Receptors of Sex Steroid Hormones in the Endometrial Tumors Technologies of Living Systems, No. 7, 2011 pp. 20-28
Matrix Metalloproteinases (MMPs) and Their Tissue Inhibitors (TIMPs), Role in the Breast Cancer Development Вопросы биологической, медицинской и фармацевтической химии, No. 12, 2011 pp. 37-46
Clinical Prospects of Matrix Metalloproteinases and Their Tissue Inhibitors Study in Ovarian Cancer Patients Вопросы биологической, медицинской и фармацевтической химии, No. 10, 2011 pp. 27-36
Epidermal Growth Factor Receptor and Receptors of Sex Steroid Hormones in the Endometrial Tumors Вопросы биологической, медицинской и фармацевтической химии, No. 10, 2011 pp. 21-26
IGF System and Breast Cancer Вопросы биологической, медицинской и фармацевтической химии, No. 10, 2011 pp. 13-20
Characteristics of Angiogenesis in Mammary Gland Вопросы биологической, медицинской и фармацевтической химии, No. 10, 2011 pp. 5-13